- Home
- CIVB vs BNTC Comparison
CIVB vs BNTC Comparison
Compare CIVB & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVB
- BNTC
- Stock Information
- Founded
- CIVB 1884
- BNTC 1995
- Country
- CIVB United States
- BNTC United States
- Employees
- CIVB N/A
- BNTC N/A
- Industry
- CIVB Major Banks
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CIVB Finance
- BNTC Health Care
- Exchange
- CIVB Nasdaq
- BNTC Nasdaq
- Market Cap
- CIVB 305.3M
- BNTC 322.6M
- IPO Year
- CIVB N/A
- BNTC N/A
- Fundamental
- Price
- CIVB $19.93
- BNTC $13.74
- Analyst Decision
- CIVB Buy
- BNTC Strong Buy
- Analyst Count
- CIVB 4
- BNTC 7
- Target Price
- CIVB $22.67
- BNTC $24.71
- AVG Volume (30 Days)
- CIVB 41.6K
- BNTC 57.0K
- Earning Date
- CIVB 04-24-2025
- BNTC 05-12-2025
- Dividend Yield
- CIVB 3.43%
- BNTC N/A
- EPS Growth
- CIVB N/A
- BNTC N/A
- EPS
- CIVB 2.01
- BNTC N/A
- Revenue
- CIVB $149,094,000.00
- BNTC N/A
- Revenue This Year
- CIVB $15.59
- BNTC N/A
- Revenue Next Year
- CIVB $5.38
- BNTC N/A
- P/E Ratio
- CIVB $9.88
- BNTC N/A
- Revenue Growth
- CIVB N/A
- BNTC N/A
- 52 Week Low
- CIVB $13.60
- BNTC $5.74
- 52 Week High
- CIVB $23.70
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- CIVB 54.67
- BNTC 55.50
- Support Level
- CIVB $18.80
- BNTC $13.26
- Resistance Level
- CIVB $20.08
- BNTC $14.22
- Average True Range (ATR)
- CIVB 0.97
- BNTC 1.29
- MACD
- CIVB 0.13
- BNTC 0.10
- Stochastic Oscillator
- CIVB 86.01
- BNTC 88.61
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.